Lineage Cell Therapeutics, Inc. (LCTX)

1.235 +0.02 (+2.07%) USD  |  NYAM  |  Jun 09, 15:19
More

Lineage Cell Therapeutics EBITDA Margin (TTM)

EBITDA Margin (TTM) Chart

View EBITDA Margin (TTM) for LCTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Margin (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Margin (TTM) Range, Past 5 Years

View EBITDA Margin (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Margin (TTM) Benchmarks

View EBITDA Margin (TTM) Benchmarks
Start Trial
Curis, Inc. Upgrade
Halozyme Therapeutics, Inc. Upgrade
Agenus, Inc. Upgrade
Amgen, Inc. Upgrade
BioCryst Pharmaceuticals, Inc. Upgrade